Spine Review


Oct. 4, 2019

1. Medtronic's brain, spine group accounts for 27% of revenue, forecasted to grow through 2021 Full story

2. Walmart pilot program to identify quality physicians will include orthopedics Full story

3. The 56 hospitals facing maximum Medicare readmission penalties Full story

4. The evolution of Dana-Farber Cancer Institute's patient experience. Attend this online discussion to hear from DFCI's CIO. 

5. Emory Healthcare building 190,000-square-foot musculoskeletal institute — 3 details Full story

6. Elite Pain & Spine Institute merges with BioHealth Pain Management Full story

7. Dr. Samuel Adams joins Alaska orthopedic practice — 3 insights Full story

8. 3 key developments in spinal cord injury treatment Full story 

9. High drug costs are pushing patients to abandon medication. Click here to learn what providers can do about it.

10. Drs. Michael Cohen, Kurtis Auguste & more: 4 spine, neurosurgeons making headlines Full story

11. Novartis eyes FDA approval of antibody following positive axial spondyloarthritis trial Full story 

12. Beyond opioids: Hospital for Special Surgery's clinical care coordinator will weigh in on emerging approaches to pain management during this live discussion

Contact Us
Editorial Contact:
Laura Dyrda
Editor in Chief
(312) 253-9170
Sales, Marketing & Events:
Jessica Cole
President and CEO
Companies to Know
Thank you to our key sponsors
Becker's Spine Review
A Becker's Healthcare Publication
17 N. State, Suite 1800| Chicago, IL 60602
View our profile on LinkedIn Follow us on Twitter Like= us on Facebook